美股A股
StockGist

Cardinal Health, Inc.

CAHNYSE · Healthcare · Medical - Distribution
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
$281.10+1.06%
报价 2026-11-13
市值
$64.97B
EV
$58.84B
PE (TTM)
31.6x
预期 PE (FY2027)
21.9x
52 周区间距高点 0.0%
$182.50$281.10

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22028-061.1x11.97 → 14.29(1.2x)19.7
FY+32029-061.2x11.97 → 15.90(1.3x)17.7

毛利率 4% · TTM 收入 $257752M · 基数 EPS 11.97(调整后)

电话会信号

辅助标签
Q1 20272026-11-05
扩产上调指引盈利拐点
指引 上调
信心 4
分析师 4

“We are raising our non-GAAP diluted EPS guidance to a new range of $12.80-$13.00, up from our prior range of $12.40-$12.60.”

原文引用(3)
  • 扩产:we are expanding 3PL and cold chain capacity through our new St. Louis facility
  • 上调指引:we are pleased to raise our fiscal 2027 EPS guidance to $12.80-$13 from the previous range of $12.40-$12.60
  • 盈利拐点:our operating income grew 17% to $1 billion, achieving that milestone in a quarter for the first time

蓝色标签在暴涨研究中略有区分度;悬停查看口径。

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
CAHCardinal Health, Inc.$64.97B+1.1%+4.1%4.3%31.6x16.9x11.9x
CORCencora, Inc.$68.51B+3.0%+4.6%4.3%23.2x13.6x15.1x
EWEdwards Lifesciences Corporation$61.61B+1.3%+12.7%78.1%44.5x32.6x43.3xGARP
ARGXargenx SE$60.37B-2.2%–89.9%38.2x39.0x58.5x
BDXBecton, Dickinson and Company$59.39B+1.1%+2.4%45.8%25.3x14.7x21.1x
AAgilent Technologies, Inc.$49.05B+0.5%+6.5%26%27.1x23.0x34.2x
VEEVVeeva Systems Inc.$48.82B-0.3%+16.5%75%48.9x36.6x29.9x
IQVIQVIA Holdings Inc.$43.69B-2.2%+8.0%32.9%33.1x16.6x16.9x
HLNHaleon plc$40.25B+0.9%–61.8%21.8x14.3x–
同行中位数––+7.2%53.8%30.1x19.8x29.9x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-06-30
Q4 2026
2026-03-31
Q3 2026
2025-12-31
Q2 2026
2025-09-30
Q1 2026
2025-06-30
Q4 2025
2025-03-31
Q3 2025
2024-12-31
Q2 2025
2024-09-30
Q1 2025
Revenue$63.86B$60.94B$65.44B$64.01B$60.16B$54.88B$55.26B$52.28B
Gross Margin4.3%4.1%3.4%3.6%3.7%3.9%3.5%3.6%
Operating Margin1.1%0.8%1.1%1%0.7%1.3%1%1.1%
Net Income$394M$399M$471M$450M$239M$506M$400M$416M
Diluted EPS1.691.691.971.8812.11.651.7
Operating Cash Flow$1.69B$1.82B$686M$973M$1.53B$2.92B$-400M$-1.65B

研究材料